Rezolute Inc (RZLT)
followers
·
Follow
1 like
| Sector: | INFORMATION TECHNOLOGY |
| Industry: | SOFTWARE |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | Nevan C. Elam |
| Employees: | 40 |
| Web site: | rezolutebio.com |
|
275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
650-206-4507
| |
-
Formally known as:
- Antriabio Inc
Are you looking for this stock instead?
| Date | Ratio |
|---|---|
| 2014-05-01 | 1:6 |
| 2020-10-13 | 1:50 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Rezolute, Inc. develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulini® an ultra-rare pediatric genetic disorder.
Please log in first to see chart